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Edited by Francesc PosasAbstract Little is known about the regulation of signal trans-
ducer and activator of transcription (STAT) stability. Here the
osmolarity-dependence of STAT3 stability, ubiquitination,
Tyr705 phosphorylation, STAT3 transactivation and c-ﬁbrinogen
(c-FBG) expression was studied in hepatoma cells. Hyper-osmo-
larity accelerated STAT3 degradation which was prevented by
proteasome inhibitors. Hypo-osmolarity stabilized STAT3, most
likely due to a decrease in STAT3 ubiquitination. Accordingly,
STAT3 Tyr705 phosphorylation, a2-macroglobulin promoter
activity and c-FBG expression were osmosensitive. Modulation
of STAT3 stability may contribute to a hydration dependence
of acute phase protein expression.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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response1. Introduction
Already small and well-tolerated changes in cell volume as
induced by ﬂuctuations of ambient osmolarity or under the
inﬂuence of hormones, substrates, second messengers, and
reactive oxygen species, importantly contribute to the regula-
tion of gene expression, metabolism, and the susceptibility to
stress, as reviewed in [1,2]. Hepatocellular swelling stimulates
anabolic pathways and proliferation and protects the liver
from diﬀerent kinds of stress, whereas hepatocellular shrinkage
triggers catabolism and insulin resistance, and sensitizes hepa-
tocytes to apoptotic stimuli. A close correlation exists between
hepatocyte hydration and autophagic proteolysis. Swelling,
e.g., in response to hypo-osmolarity or insulin inhibits of auto-
phagic proteolysis [3], whereas shrinkage as induced by hyper-
osmolarity or glucagon prevents inhibition of autophagic
proteolysis by insulin [4]. Little is known about the hydration
dependence of proteasomal proteolysis.
The signal transducer and activator of transcription
(STAT3) plays a major role in cytokine and growth factor sig-Abbreviations: STAT, signal transducer and activator of transcription;
a2M, a2-macroglobulin; c-FBG, c-ﬁbrinogen
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dimerization of STAT3, allowing its translocation into the
nucleus and transactivation of target genes [5]. In liver, STAT3
is involved in activation of the acute phase response [5] and
plays a major role in liver regeneration [6], hepatoprotection
[7,8], and insulin signaling [9].
Here, it is reported that aniso-osmolarity modulates STAT3
ubiquitination and stability, STAT3 Tyr705 phosphorylation,
transactivation of a STAT3-dependent reporter, and c-ﬁbrino-
gen (c-FBG) expression in hepatoma cells. It is suggested that
osmotic regulation of STAT3 availability and phosphorylation
contributes a hydration dependence of acute phase protein
expression.2. Materials and methods
2.1. Materials
The antibodies raised against STAT3 and STAT3 phosphorylated
on Tyr705 were from Santa Cruz Biotechnology (Santa Cruz, CA,
USA) and Cell Signaling (Beverly, MA, USA). The anti-GAPDH anti-
body was from Biodesign International (Cologne, Germany) and the
anti-ubiquitin antibody was from DAKO (Glostrup, Denmark). The
anti-c-FBG antibody was from Upstate (Charlottesville, VA, USA).
MG-132 and lactacystin were from Calbiochem–Novabiochem GmbH
(Darmstadt, Germany). Cell culture media and fetal calf serum were
from Gibco Life Technologies (Gaithersburg, MD). IL-22 and 3-
methyladenine were from Sigma (Munich, Germany). All other chem-
icals were from Merck (Darmstadt, Germany). Densitometric analysis
was performed with the Scion Image Software (Scion Corporation,
Frederick, MD, USA).
2.2. Cell culture and experimental treatment of the cells
H4IIE-C3 rat hepatoma cells were maintained on Cluster six dishes
(Greiner, Frickenhausen, Germany) in DMEM-F12/5%CO2/5 mM
glucose at 37 C, pH7.4, supplemented with 10% FCS. When cells
had reached about 90% conﬂuency, they were washed with phos-
phate-buﬀered saline and the culture was continued in 1.5 ml serum-
free medium for an additional 24 h. Hyper-osmolarity (405 mosmol/
l) and hypo-osmolarity (205 mosmol/l) were adjusted by dilution with
medium of elevated NaCl or without NaCl, respectively. In the normo-
osmotic control (305 mosmol/l), an identical volume of normo-osmotic
medium was added.
2.3. RT-PCR analysis of STAT3 mRNA expression
The expression of STAT3,GAPDHandCOXIVmRNAwas analyzed
by real-time PCR. Primers were designed with FastPCR (R. Kalendar,
Institute of Biotechnology/Helsinki http://www.biocenter.helsinki.ﬁ/bi/
bare-1_html/download.htm) and synthesized by Qiagen (Hilden, Ger-
many). Total RNA was prepared with the RNeasy Midi Kit (Qiagen)
and analyzed spectrometrically and by capillary electrophoresis (Bioana-
lyser,AgilentTechnologies). Reverse transcription andPCRwere done in
a single step reaction using the QuantiTect SYBR Green RT-PCR Kitation of European Biochemical Societies.
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lyzed with four diﬀerent primer combinations. The reaction was per-
formed in a PE Biosystems GeneAmp 7700 sequence detection in
MicroAmp 96-well plates capped with MicroAmp optical caps. The fol-
lowing program was used: stage (1) 30 min 50 C; stage (2) 15 min
95 C; stage (3) 30 s 62 C; 60 s 72 C; 15 s 95 C; 40 cycles. The ﬂuores-
cence was measured during the extension step.
The PCRs were subjected to a heat dissociation protocol (PE Biosys-
tems 7700 software). Following the ﬁnal cycle of the PCR, the reac-
tions were heat denaturated over a 35 C temperature gradient at
0.03 C s1 from 60 to 95 C. Each PCR product showed a single peak
in the denaturation curves.
The real-time PCR data were plotted as the ﬂuorescence signal ver-
sus the cycle number. The PE Biosystems 7700 sequence detection sys-
tem software calculates the Rn using the equation:
hRn ¼ ðRþn Þ  ðRn Þ;
where Rþn is the ﬂuorescence signal of the product at any given time and
Rn is the ﬂuorescence signal of the baseline emission during cycles 6–
15. An arbitrary threshold was set at the midpoint of logRn versus cy-
cle number plot. The Ct value is deﬁned as the cycle number at which
the Rn crosses this threshold. The relative change in target gene cDNA
to untreated rats was determined by
change ¼ 2ðCtðt¼xÞCtðt¼0ÞÞ.
Time x is any time point and time 0 represents the rats before change
of osmotic conditions. STAT3 mRNA expression was normalized to
the expression of GAPDH and COXIV mRNA.
2.4. Western blot analysis
At the end of the experimental treatment, medium was removed
from the culture and cells were immediately lysed at 4 C using
10 mM Tris–HCl buﬀer (pH 7.4) containing 1% Triton X-100, 0.5%
NP-40, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 20 mM NaF
and 1 tablet/50 ml of protease inhibitor cocktail (Roche Diagnostics
GmbH, Mannheim, Germany). The homogenized lysates were centri-
fuged at 20000 ·g at 4 C for 10 min. To perform SDS–polyacrylamide
gel electrophoresis and Western Blot analysis, the supernatant was
added to an identical volume of 2· gel loading buﬀer containing
200 mM dithiothreitol (DTT, pH 6.8). After heating to 95 C for
5 min, proteins were subjected to SDS–PAGE (60 lg protein/lane).
Following electrophoresis, gels were equilibrated with transfer buﬀer
(39 mM glycine, 48 mM Tris–HCl, 0.03% SDS, 20% methanol). Pro-
teins were transferred to nitrocellulose membranes using a semi-dry
transfer apparatus (Pharmacia, Freiburg, Germany). Blots were
blocked overnight in 5% bovine serum albumin solubilized in 20 mM
Tris–HCl (pH 7.5) containing 150 mM NaCl and 0.1% Tween 20
and then incubated for 3–4 h with the anti-STAT3 diluted 1:3000. Fol-
lowing washing and incubation for 2 h with horseradish peroxidase-
coupled anti-rabbit-IgG antibody (1:10000–1:20000, 4 C) the blots
were washed again and developed using enhanced chemiluminescent
detection (Amersham Biosciences Europe, Freiburg, Germany).
2.5. Analysis of protein ubiquitination
For analysis of ubiquitination 180 lg protein were incubated with
sepharose coupled to the proteasome subunit S5a (Aﬃniti, Exeter,
UK) in standard binding buﬀer (TBS, 20 mM Tris–HCl, pH 7.5,
0.15 M NaCl) for 4 h at 4.0 C and afterwards centrifuged for 2 min
(4000 rpm, 4.0 C) and then washed with binding buﬀer. Half of the
pellet was incubated in hydrolase buﬀer (50 mM HEPES, pH 7.5,
1 mM DTT) and incubated with 0.19 lM ubiquitin hydrolase (Aﬃniti,
Exeter, UK) for 7 h at 37 C. S5a-bound proteins were analyzed by
Western Blot for the presence of STAT3 and ubiquitin, respectively.2.6. Transfection procedure and reporter gene assay of a2-macroglobulin
promoter activity
For the reporter gene assay, human HepG2 hepatoma cells were
transfected using LIPOFECTAMINE 2000 (Invitrogen; Karlsruhe,
Germany). In brief, 1.6 lg of the reporter plasmid pGL3a2M-215Luc
(contains the promoter region 209 to +8 of the rat a2-macroglobulin
(a2M) gene fused to the luciferase-encoding sequence) and 0.1 lg Re-
nilla expression vector pRLTK (Promega; Madison, WI, USA) diluted
in 50 ll of Opti-MEM and 3 ll LIPOFECTAMINE 2000 diluted in250 ll of Opti-MEM were mixed and incubated for 20 min at room
temperature. Meanwhile, HepG2 cells grown to conﬂuence were tryp-
sinized and resuspended in DMEM-F12 plus 10% FCS. 300 ll of the
cell suspension were added to the transfection mixture. Thereafter,
1 ml of culture medium was added and cells were seeded on 6-well
plates. After 5 h medium was exchanged against DMEM-F12/10%
FCS containing streptomycin (100 mg/l) and penicillin (60 mg/l). After
another 24 h medium was replaced by hypo-, normo- or hyper-osmotic
media without further additives or containing IL-22 (10 ng/ml) or IL-6
(100 U/ml), respectively. Cell lysis and luciferase assays were con-
ducted using the dual-luciferase kit (Promega, Mannheim, Germany)
according to the manufacturers instructions.2.7. Analysis of results
Results from n independent experiments are expressed as means ±
S.E.M. Results were compared using the Students t-test: P 6 0.05
was considered statistically signiﬁcant.3. Results
Hyper-osmotic exposure of H4IIE cells signiﬁcantly reduced
STAT3 expression levels, whereas hypo-osmolarity tended to
increase STAT3 expression compared to that found under
the normo-osmotic control condition (Fig. 1A). Aniso-osmo-
larity was largely without eﬀect on STAT3 mRNA expression
levels (Fig. 1B), suggesting that osmotic modulation of STAT
expression occurs mainly at the protein level.
To examine a potential osmosensitivity of STAT3 stability,
the protein synthesis inhibitor cycloheximide (CHX) was
applied. Fig. 2 shows that STAT3 expression in the presence
of CHX decreased more rapidly under hyper-osmotic condi-
tions, whereas hypo-osmolarity attenuated the STAT3
decline. This indicates that STAT3 degradation is osmotically
regulated.
As shown in Fig. 3A, the proteasome inhibitors MG-132
and lactacystin [10] prevented hyper-osmotic suppression of
STAT3 expression. The inhibitor of autophagic proteolysis
3-methyladenine (3-MA) [11] was ineﬀective to antagonize
the hyper-osmotic decrease of STAT3 expression. In order to
exclude a potential de novo synthesis of STAT3 stimulated
by the proteasome inhibitors, MG-132 and, for comparison,
3-MA were applied in the presence of CHX. As shown in
Fig. 3B, MG-132 maintained STAT3 expression stable, irre-
spective of ambient osmolarity. On the other hand, 3-MA
was ineﬀective to antagonize hyper-osmotic STAT3 degrada-
tion, suggesting proteasomal rather than autophagic STAT3
degradation to be involved.
In order to study ubiquitination of STAT3, ubiquitinated
proteins were allowed to accumulate in the presence of MG-
132 and extracted by S5a-sepharose. As shown in
Fig. 4(lower part), the overall accumulation of ubiquitinated
proteins was decreased under hypo-osmotic but increased un-
der hyper-osmotic conditions. Treatment of S5a-sepharose-
bound proteins with ubiquitin hydrolase resulted in overall
de-ubiquitination (Fig. 4, lower part). This was associated with
a recovery of non-ubiquitinated STAT3, which was less under
hypo-osmotic conditions (Fig. 4, upper part, arrow). Com-
pared to the normo-osmotic control, hyper-osmolarity did
not further increase the recovery of free STAT3, suggesting
that an additional ubiquitination does not account for the hy-
per-osmotic destabilization of STAT3.
IL-22, a recently discovered IL-10-like cytokine stimulating
the hepatic acute phase response, triggers in H4IIE cells a pro-
Fig. 1. Osmosensitivity of STAT3 expression. H4IIE cells were incubated in hypo-, normo-, or hyper-osmotic medium for the time periods indicated.
At the end of the incubations cells were lysed. (A) Proteins were analyzed for STAT3 expression by Western blot. A representative of 3 (3, 12 and 24 h
time points) and 11 (6 h time point) independent experiments is shown. STAT3 expression was normalized to expression of GAPDH. STAT3
expression under the respective normo-osmotic condition was set to 1. (B) Total RNA was analyzed for expression of STAT3 mRNA by real-time
PCR and quantiﬁed as described in Section 2. STAT3 mRNA expression under the respective normo-osmotic condition was set to 1. \, STAT3
mRNA or protein expression under hypo- or hyper-osmotic conditions signiﬁcantly (P 6 0.05) diﬀerent from that found under normo-osmotic
conditions.
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shown in Fig. 5, the IL-22-induced Tyr705-phosphorylation
of STAT3 was slightly increased under hypo-osmotic condi-
tions but largely absent under hyper-osmotic conditions. No
Tyr705 phosphorylation of STAT3 was triggered by aniso-
osmolarity per se.
The reporter plasmid pGL3a2M-215Luc is mainly con-
trolled by the STAT3-binding tandem motif of the rat a2-M
promotor [13] and was used to study the osmosensitivity of
STAT3-dependent transactivation of genes. Fig. 6 shows thathyper-osmolarity decreased and hypo-osmolarity increased ba-
sal a2M promoter activity. In addition, hyper-osmolarity inter-
fered with IL-22- and IL-6-induced transcriptional activation
of the STAT-3-dependent reporter.
Induction of the human acute phase protein c-FBG in
HepG2 cells depends on STAT3 [14]. Fig. 7 shows that
hypo-osmolarity tended to increase, whereas hyper-osmolarity
signiﬁcantly decreased basal c-FBG expression by HepG2
cells. c-FBG induction in response to IL-6 or IL-22 was
blunted under hyper-osmotic conditions (Fig. 7).
Fig. 2. Osmosensitivity of STAT3 degradation. H4IIE cells were lyzed
(zero time point) or exposed for another 3, 6 or 12 h to hypo (¤)-,
normo (n),- or hyper-osmotic (m) medium in the presence of 5 lg/ml
CHX. STAT3 expression was monitored by Western blot. A repre-
sentative of 3–8 independent experiments is shown. STAT3 expression
at the zero time point was set to 1 and STAT3 expression at the later
time points is given as a fraction thereof. STAT3 expression after 3, 6
and 12 h signiﬁcantly diﬀers from that found at the zero time point,
irrespective of the ambient osmolarity. \, STAT3 expression signiﬁ-
cantly (P 6 0.05) diﬀerent from that found under the respective
normo-osmotic condition. §, STAT3 expression signiﬁcantly (P 6 0.05)
diﬀerent from that found under the respective hypo-osmotic condition.
Fig. 3. Eﬀect of proteolysis inhibitors on hyper-osmotic suppression
of STAT3 expression. H4IIE cells were lyzed (zero time point) or
incubated in hypo-, normo-, or hyper-osmotic medium for another
6 h without further additives (control) or in the presence of 25 lM
MG-132, 5 lM lactacystin, and 10 mM 3-MA, as indicated. Lysates
were analyzed for STAT3 expression by Western blot. (A) Incuba-
tions in the absence of CHX. A representative of 3–11 independent
experiments is shown. STAT3 expression was normalized to
expression of GAPDH. STAT3 expression under the respective
normo-osmotic condition was set to 1. \, STAT3 expression
signiﬁcantly (P 6 0.05) diﬀerent from that found under the respec-
tive normo-osmotic condition. (B) Incubations in the presence of
5 lM CHX. A representative of 3–8 independent experiments is
shown. STAT3 expression at the zero time point was set to 1 and
STAT3 expression at the later time points is given as a fraction
thereof. \, STAT3 expression signiﬁcantly (P 6 0.05) diﬀerent from
that found at the zero time point. §, STAT3 expression signiﬁcantly
(P 6 0.05) diﬀerent from that found under the normo-osmotic
control condition.
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As reported here STAT3 stability is osmotically regulated.
Hypo-osmolarity (205 mosmol/l) stabilizes STAT3 most likely
by decreasing its ubiquitination, whereas hyper-osmolarity
(405 mosmol/l) accelerates proteasomal STAT3 degradation
probably by ubiquitin-dependent and independent mecha-
nisms (Figs. 1–4). It is suggested that STAT3 degradation con-
tributes to the hyper-osmotic impairment of STAT3 Tyr705
phosphorylation (Fig. 5), a2M promoter activity (Fig. 6) and
c-FBG expression (Fig. 7).
Further examples for an osmosensitivity of proteasomal deg-
radation include the hyper-osmotic degradation of heme oxy-
genase-1 in hepatocytes [15], of cyclin D1 in Granta519 cells
[16], and of ornithine decarboxylase (ubiquitin-independent)
in HTC hepatomas [17]. Hyper-osmotic degradation of the
insulin receptor substrate IRS-1 in 3T3-L1 adipocytes was trig-
gered by a proteasome-independent mechanism [18]. Hyper-
osmolarity did not increase proteolysis of the MAP-kinase
phosphatase MKP-1 in H4IIE cells although this enzyme is de-
graded by the proteasome [19]. Overall, these ﬁndings suggest
that cellular dehydration diﬀerentially aﬀects proteasomal deg-
radation at the level of individual proteins.
Fig. 4. Osmosensitivity of MG-132-induced accumulation of ubiqui-
tinated proteins. H4IIE cells were exposed to MG-132 (25 lM) under
normo- or hyper-osmotic conditions (305 and 405 mosmol/l). Cells
were lyzed after 6 h and ubiquitinated proteins were extracted by S5a-
sepharose. Ubiquitinated proteins eluted from the S5a-sepharose were
treated with ubiquitin hydrolase where indicated and analyzed by
Western blot for the presence of STAT3 (upper part) or ubiquitin
(lower part), respectively. Ubiquitin hydrolase treatment decreases
ubiquitin immunoreactivity and simultaneously increases the recovery
of non-ubiquitinylated STAT3 (arrow). Representatives of three
independent experiments are shown.
Fig. 6. Osmosensitive activation of the rat a2-M promotor by IL-22
and IL-6. HepG2 cells cotransfected with the reporter construct
pGL3a2M-215Luc and the Renilla expression vector pRLTK were
exposed to hypo-, normo- or hyper-osmotic medium for 16 h in the
presence or absence of IL-22 (A, 10 ng/ml) or IL-6 (B, 100 U/ml). a2M
promoter activity was addressed as described in Section 2. Luciferase
activity normalized to transfection eﬃciency as monitored by the co-
transfected pRLTK was taken as a measure for a2M promoter activity
and presented as percentage of that found in the respective controls
(IL-22 or IL-6 under normo-osmotic conditions). #P 6 0.05, compared
to the control experiment; \P 6 0.05, compared to that found in the
absence of the cytokine under the respective osmotic condition;
P 6 0.05, compared to that found in absence of cytokine addition
under normo-osmotic conditions.
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susceptibility of some cell types to diﬀerent kinds of stress
[1,2]. On the other hand, hyper-osmolarity without an addi-
tional challenge is well tolerated by hepatocytes (including
H4IIE cells [20]) and produces pleiotropic eﬀects at the levels
of signal transduction and protein expression [1,2]. In H4IIE
cells, hyper-osmolarity increases heat shock protein 70 expres-
sion in response to heat and thereby even improved the stress
tolerance of the cells [20]. Severe hyper-osmolarity (600 mM
sorbitol) in HepG2 cells increased STAT3 Tyr705 phosphoryla-Fig. 5. Osmosensitivity of STAT3 Tyr705 phosphorylation by IL-22. H4IIE cells were incubated in hypo-, normo- or hyper-osmotic medium for 6 h.
When indicated cells were exposed to 10 ng/ml IL-22 for another 15 min. Cells were lyzed and proteins were analyzed for the presence of Tyr705-
phosphorylated STAT3 and STAT3 by probing Western blots with antibodies recognizing Tyr705-phosphorylated and overall STAT3, respectively.
Blots were quantiﬁed by densitometry. A representative of three independent experiments is shown. Levels of Tyr705-phosphorylated STAT3 was
normalized to overall STAT3 levels. STAT3 expression and Tyr705 phosphorylation under the normo-osmotic control condition were set to 1. \,
STAT3 expression (Tyr705 phosphorylation) signiﬁcantly (P 6 0.05) diﬀerent from that found under the normo-osmotic control condition. §, hyper-
osmotic inhibition of IL-22-induced STAT3 Tyr705 phosphorylation signiﬁcantly (P 6 0.05) exceeds hyper-osmotic reduction of STAT-3 expression.
Fig. 7. Osmosensitive c-FBG expression by IL-6 and IL-22. HepG2
cells were exposed to hypo-, normo-, or hyper-osmotic medium for 6 h
in the presence or absence of IL-6 (100 U/ml) or IL-22 (10 ng/ml) as
indicated. Cells were lyzed and Western Blots were analyzed for the
presence of c-FBG and GAPDH, respectively. Blots were quantiﬁed by
densitometry. A representative of three independent experiments is
shown. c-FBG levels were normalized to GAPDH expression. c-FBG
expression under the normo-osmotic condition in the absence of added
cytokines was set to 1. \P 6 0.05 compared to c-FBG expression in the
absence of added cytokine under the respective osmotic condition;
$ P 6 0.05 from c-FBG expression induced by the respective cytokine
under the normo-osmotic condition; §P 6 0.05 compared to c-FBG
induction by IL-6; P 6 0.05 compared to c-FBG expression under the
normo-osmotic condition in the absence of added cytokine.
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dependent reporter [21]. These and other observations suggest
that the modulation of STAT3 stability and STAT3-dependent
gene expression by moderate changes in ambient osmolarity as
reported here do not reﬂect a general impairment of vital pro-
cesses but is rather part of a complex and co-ordinated cellular
response.
Selective degradation of STAT3 by the proteasome was re-
cently suggested to contribute to growth suppression and
apoptosis of hematopoietic cells experimentally treated with
ubiquitin [22]. Targeted proteasomal degradation of STAT1
and STAT3 by the mumps virus contributes to evasion of anti-
viral responses and the oncolytic potential of the virus [23].
Interestingly, an artiﬁcial liver-speciﬁc knockout of STAT3
expression in mice confers insulin resistance and hyperglyce-
mia [9]. Hepatic STAT3 depletion under dehydrating condi-
tions impairs acute phase protein expression and may
contribute to insulin resistance, inhibition of proliferation,
and sensitization of hepatocytes to apoptotic stimuli. On the
other hand, stabilization of STAT3 under conditions of hepa-
tocellular swelling may support insulin sensitivity, prolifera-
tion, and help to protect cells from adverse conditions.
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